Cargando…

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

OBJECTIVE: To test blood and CSF neurofilament light chain (NfL) levels in relation to disease progression and survival in amyotrophic lateral sclerosis (ALS). METHODS: Using an electrochemiluminescence immunoassay, NfL levels were measured in samples from 2 cohorts of patients with sporadic ALS and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Ching-Hua, Macdonald-Wallis, Corrie, Gray, Elizabeth, Pearce, Neil, Petzold, Axel, Norgren, Niklas, Giovannoni, Gavin, Fratta, Pietro, Sidle, Katie, Fish, Mark, Orrell, Richard, Howard, Robin, Talbot, Kevin, Greensmith, Linda, Kuhle, Jens, Turner, Martin R., Malaspina, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456658/ https://www.ncbi.nlm.nih.gov/pubmed/25934855 http://dx.doi.org/10.1212/WNL.0000000000001642

Ejemplares similares

Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study
por: Lu, Ching-Hua, et al.
Publicado: (2015)

Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis
por: Lu, Ching-Hua, et al.
Publicado: (2016)

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
por: Gaiottino, Johanna, et al.
Publicado: (2013)

CSF neurofilament light chain reflects corticospinal tract degeneration in ALS
por: Menke, Ricarda A L, et al.
Publicado: (2015)

Plasma Neurofilament Heavy Chain Levels Correlate to Markers of Late Stage Disease Progression and Treatment Response in SOD1(G93A) Mice that Model ALS
por: Lu, Ching-Hua, et al.
Publicado: (2012)

Profilin1 E117G is a moderate risk factor for amyotrophic lateral sclerosis
por: Fratta, Pietro, et al.
Publicado: (2014)

Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain
por: Thompson, Alexander G., et al.
Publicado: (2022)

Antibodies to neurofilament light as potential biomarkers in multiple sclerosis
por: Puentes, Fabiola, et al.
Publicado: (2021)

Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis
por: Davies, Jennifer C, et al.
Publicado: (2023)

The potential of neurofilaments analysis using dry-blood and plasma spots
por: Lombardi, Vittoria, et al.
Publicado: (2020)

A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK
por: Morgan, Sarah, et al.
Publicado: (2017)

Author Correction: The potential of neurofilaments analysis using dry-blood and plasma spots
por: Lombardi, Vittoria, et al.
Publicado: (2020)

Humoral response to neurofilaments and dipeptide repeats in ALS progression
por: Puentes, Fabiola, et al.
Publicado: (2021)

The 2022 Lady Estelle Wolfson lectureship on neurofilaments
por: Petzold, Axel
Publicado: (2022)

The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy
por: Spicer, Charlotte, et al.
Publicado: (2021)

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2015)

Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal
por: Benatar, Michael, et al.
Publicado: (2022)

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
por: Shahim, Pashtun, et al.
Publicado: (2016)

Blood neurofilament light chain at the doorstep of clinical application
por: Leppert, David, et al.
Publicado: (2019)

Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
por: Falzone, Yuri Matteo, et al.
Publicado: (2021)

Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis
por: De Schaepdryver, Maxim, et al.
Publicado: (2022)

The Diagnostic and Prognostic Value of Neurofilament Heavy Chain Levels in Immune-Mediated Optic Neuropathies
por: Petzold, Axel, et al.
Publicado: (2012)

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
por: Bergman, Joakim, et al.
Publicado: (2016)

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
por: Steinacker, Petra, et al.
Publicado: (2011)

Opinion: more mouse models and more translation needed for ALS
por: Fisher, Elizabeth M.C., et al.
Publicado: (2023)

Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction
por: Vågberg, Mattias, et al.
Publicado: (2015)

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
por: Shi, Jiaying, et al.
Publicado: (2021)

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders
por: Herbert, Megan K., et al.
Publicado: (2015)

Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion()
por: Fratta, Pietro, et al.
Publicado: (2015)

Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis
por: Povedano Panades, Mónica, et al.
Publicado: (2021)

Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis
por: Gao, Jiali, et al.
Publicado: (2022)

CSF neurofilament light chain testing as an aid to determine treatment strategies in MS
por: Reyes, Saúl, et al.
Publicado: (2020)

Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis
por: Joilin, Greig, et al.
Publicado: (2020)

Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity
por: Klickovic, Uros, et al.
Publicado: (2019)

The proteome of neurofilament-containing protein aggregates in blood
por: Adiutori, Rocco, et al.
Publicado: (2018)

Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
por: Xu, Zhouwei, et al.
Publicado: (2016)

Role of Blood Neurofilaments in the Prognosis of Amyotrophic Lateral Sclerosis: A Meta-Analysis
por: Zhou, Yan-ni, et al.
Publicado: (2021)

Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
por: Verde, Federico, et al.
Publicado: (2023)

Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathology()
por: Petzold, Axel, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9jk1omsip9pjshrutc0vdkurfr